Achim Jungbluth

1.2k total citations · 1 hit paper
13 papers, 1.0k citations indexed

About

Achim Jungbluth is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Achim Jungbluth has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Achim Jungbluth's work include Immunotherapy and Immune Responses (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Achim Jungbluth is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). Achim Jungbluth collaborates with scholars based in United States, Switzerland and Australia. Achim Jungbluth's co-authors include Michael W. Marino, Lloyd J. Old, Yuji Noguchi, Melissa Inglese, Ashley R. Dunn, Dianne Grail, Hisashi Wada, Malcolm A.S. Moore, Sunanda Basu and Elizabeth Richards and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Achim Jungbluth

13 papers receiving 1.0k citations

Hit Papers

Characterization of tumor necrosis factor-deficient mice 1997 2026 2006 2016 1997 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Characterization of tumor necrosis factor-deficient mice
    1997 675 citations Michael W. Marino, Ashley R. Dunn et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Achim Jungbluth United States 10 541 244 233 147 134 13 1.0k
Ian D. Haidl Canada 17 600 1.1× 270 1.1× 199 0.9× 113 0.8× 53 0.4× 32 1.1k
Tim Bourne United Kingdom 15 748 1.4× 274 1.1× 178 0.8× 149 1.0× 94 0.7× 24 1.4k
Colette Charland United States 15 493 0.9× 288 1.2× 206 0.9× 185 1.3× 74 0.6× 21 1.1k
Simone Bürgler Switzerland 13 714 1.3× 285 1.2× 135 0.6× 257 1.7× 70 0.5× 22 1.4k
Hans‐Gerd Pauels Germany 13 548 1.0× 264 1.1× 217 0.9× 150 1.0× 39 0.3× 26 1.2k
Mark KuKuruga United States 18 360 0.7× 215 0.9× 144 0.6× 189 1.3× 128 1.0× 40 921
Ludmila N. Drutskaya United States 8 635 1.2× 147 0.6× 177 0.8× 117 0.8× 46 0.3× 9 953
Irene Puga United States 15 1.1k 1.9× 390 1.6× 118 0.5× 170 1.2× 57 0.4× 19 1.5k
Hossein Asgarian‐Omran Iran 22 637 1.2× 347 1.4× 145 0.6× 311 2.1× 68 0.5× 106 1.3k
Brigitte Bartsch Germany 10 553 1.0× 287 1.2× 319 1.4× 237 1.6× 416 3.1× 13 1.6k

Countries citing papers authored by Achim Jungbluth

Since Specialization
Citations

This map shows the geographic impact of Achim Jungbluth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achim Jungbluth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achim Jungbluth more than expected).

Fields of papers citing papers by Achim Jungbluth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Achim Jungbluth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achim Jungbluth. The network helps show where Achim Jungbluth may publish in the future.

Co-authorship network of co-authors of Achim Jungbluth

This figure shows the co-authorship network connecting the top 25 collaborators of Achim Jungbluth. A scholar is included among the top collaborators of Achim Jungbluth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Achim Jungbluth. Achim Jungbluth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Chung, Sebastian, Darren R. Veach, Edward K. Fung, et al.. (2021). Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis. Molecular Cancer Therapeutics. 21(1). 125–137. 11 indexed citations
2.
Lu, Chuanyong, Daniel C. Ramirez, Sinchun Hwang, et al.. (2018). Histone H3K36M mutation and trimethylation patterns in chondroblastoma. Histopathology. 74(2). 291–299. 24 indexed citations
3.
Sabado, Rachel Lubong, Anna C. Pavlick, Sacha Gnjatic, et al.. (2013). Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma. Journal for ImmunoTherapy of Cancer. 1(S1). 4 indexed citations
4.
Clark, Rachael A., Nicole Hanson, Jodie Tassello, et al.. (2010). Cervical mucosal CD8 T cells are more predictive of HPV lesion regression than systemic HPV-specific response (48.13). The Journal of Immunology. 184(Supplement_1). 48.13–48.13. 1 indexed citations
5.
Cho, Hearn Jay, Maurizio DiLiberto, Xiangao Huang, et al.. (2009). MAGE-A3 Inhibits p53 and Promotes Proliferation and Survival in Multiple Myeloma.. Blood. 114(22). 1795–1795. 1 indexed citations
6.
Pérez, Daniel, et al.. (2007). Protein S100 as Prognostic Marker for Gastrointestinal Stromal Tumors: A Clinicopathological Risk Factor Analysis. Journal of Investigative Surgery. 20(3). 181–186. 10 indexed citations
7.
Tammela, Jonathan, Akiko Uenaka, Toshiro Ono, et al.. (2006). OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer. International Journal of Oncology. 29(4). 903–10. 35 indexed citations
8.
Welt, Sydney, Gerd Ritter, Clarence Williams, et al.. (2003). Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer.. PubMed. 9(4). 1347–53. 31 indexed citations
9.
Deckert, P. Markus, Achim Jungbluth, Mike A. Clark, et al.. (2000). Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts. International Journal of Cancer. 87(3). 382–390. 20 indexed citations
10.
Murray, Henry W., et al.. (2000). Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment. Infection and Immunity. 68(11). 6289–6293. 91 indexed citations
11.
Murray, Henry W., et al.. (2000). Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment. Infection and Immunity. 68(11). 6289–6293. 9 indexed citations
12.
Marino, Michael W., Maureen R. Horton, Achim Jungbluth, et al.. (1998). Inhibition of interferon γ induced interleukin 12 production: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proceedings of the National Academy of Sciences. 95(23). 13806–13811. 127 indexed citations
13.
Marino, Michael W., Ashley R. Dunn, Dianne Grail, et al.. (1997). Characterization of tumor necrosis factor-deficient mice. Proceedings of the National Academy of Sciences. 94(15). 8093–8098. 675 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ian D. Haidl Breakdown of academic impact, for papers by Tim Bourne Breakdown of academic impact, for papers by Colette Charland Breakdown of academic impact, for papers by Simone Bürgler Breakdown of academic impact, for papers by Hans‐Gerd Pauels Breakdown of academic impact, for papers by Mark KuKuruga Breakdown of academic impact, for papers by Ludmila N. Drutskaya Breakdown of academic impact, for papers by Irene Puga Breakdown of academic impact, for papers by Hossein Asgarian‐Omran Breakdown of academic impact, for papers by Brigitte Bartsch
Rankless by CCL
2026